Back to trial detailsIntake questionnaire
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Applying to Great Lakes Clinical Trials - Ravenswood · Chicago, Illinois
Answer a few short questions to share with the research team.
0 of 4 answered